ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.

Xian-De Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.